January 2021

Siemens Healthcare Diagnostics Inc. (January 14, 2021)

IsoSciences, LLC (January 14, 2021)

Cedarburg Pharmaceuticals (January 12, 2021)

Organix, Inc. (January 12, 2021)

Siegfried USA, LLC (January 12, 2021)

Natural Fulfillment LLC (January 12, 2021)

Medi-Physics, Inc. dba GE Healthcare (January 12, 2021)

S&B Pharma LLC dba Norac Pharma (January 12, 2021)

Proposed Rule: Amending Regulations To Require Online Submission of Applications for and Renewals of DEA Registration (PDF) (January 7, 2021)

---

December 2020

Brian M. Manjarres, M.D.; Decision and Order (Tuesday, December 29, 2020)

Irene G. Gurvits, M.D.; Decision and Order (Tuesday, December 29, 2020)

Annamalai Ashokan, M.D.; Decision and Order (Tuesday, December 29, 2020)

Steven M. Kotsonis, M.D.; Order (Tuesday, December 29, 2020)

Fresenius Kabi USA, LLC (December 22, 2020)

Yourway Transport (December 22, 2020)

Organic Standards Solutions International, LLC (December 22, 2020)

Proposed Rule: Designation of 3,4-MDP-2-P Methyl Glycidate (PMK Glycidate), 3,4-MDP-2-P Methyl Glycidic Acid (PMK Glycidic Acid), and Alpha-Phenylacetoacetamide (APAA) as List I Chemicals (December 21, 2020)

Final Rule: Controls To Enhance the Cultivation of Marihuana for Research in the United States (PDF) (December 18, 2020)

Order With Opportunity for Comment: Exempt Anabolic Steroid Products (December 16, 2020)

Sterling Wisconsin, LLC (December 15, 2020)

Adiramedica LLC (December 15, 2020)

Sterling Pharma USA, LLC (December 11, 2020)

Johnson Matthey, Inc. (December 11, 2020)

King Wong, M.D.; Decision and Order (December 11, 2020)

Zeljko Stjepanovic, M.D.; Decision and Order (December 11, 2020)

Anindita Nandi, M.D.; Decision and Order (December 11, 2020)

Lisa Hofschulz, N.P.; Decision and Order (December 11, 2020)

Poplar Grove Pharmacy Inc.; Decision and Order (December 11, 2020)

Ernesto C. Torres, M.D.; Decision and Order (December 11, 2020)

George Pursley, M.D.; Denial of Application (PDF) (December 11, 2020)

Proposed Rule: Removal of Samidorphan From Control (December 10, 2020)

Johnson Matthey Inc. (December 8, 2020)

Proposed Rule: Partial Filling of Prescriptions for Schedule II Controlled Substances (PDF) (December 4, 2020)

Janssen Pharmaceuticals Inc. (December 4, 2020)

Notice of Intent: Temporary Placement of Brorphine in Schedule I (December 3, 2020)

Janssen Pharmaceuticals Inc. (December 3, 2020)

Final Adjusted Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2020 (December 1, 2020)

---

November

Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2021 (November 30, 2020)

Novitium Pharma LLC (November 27, 2020)

Meridian Medical Technologies (November 27, 2020)

Noramco Inc. (November 27, 2020)

Lyndra Therapeutics (November 27, 2020)

Final Rule: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl in Schedule I (November 25, 2020)

Johnson Matthey Pharmaceutical Materials Inc. (November 23, 2020)

Lewis Leavitt III, M.D.; Decision and Order (November 19, 2020)

Suntree Pharmacy and Suntree Medical Equipment, LLC; Decision and Order (PDF) (November 19, 2020)

ECO Apothecary, LLC; Decision and Order (November 19, 2020)

Monica Ferguson, F.N.P., R.N.; Decision and Order (November 19, 2020)

Jeffrey M. Wolk, M.D.; Decision and Order (November 19, 2020)

Julie I. Dee, M.D.; Decision and Order (November 19, 2020)

Verne A. Schwager, M.D.; Decision and Order (November 19, 2020)

Jeanne E. Germeil, M.D. Decision and Order (PDF) (November 19, 2020)

Hil Rizvi, M.D.; Decision and Order (November 19, 2020)

Jonathan Rosenfield, M.D.; Decision and Order (November 19, 2020)

Navinta LLC (November 4, 2020)

Cerilliant Corporation (November 4, 2020)

Proposed Rule: Suspicious Orders of Controlled Substances (PDF) (November 2, 2020)

Interim Final Rule: Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment (PDF) (November 2, 2020)

---

October

Interim Final Rule: Placement of Oliceridine in Schedule II (October 30, 2020)

Final Rule: Implementation of the Combat Methamphetamine Epidemic Act of 2005; Retail Sales; Notice of Transfers Following Importation or Exportation (October 29, 2020)

Contract Pharmacal Corp. (October 28, 2020)

ARCOS Retail Drug Summary Report (Jan-Jun 2020)

API GLOBAL LLC (October 27, 2020)

Mylan Pharmaceuticals (October 27, 2020)

Mylan Technologies Inc. (October 23, 2020)

Final Rule: Implementation of the Ryan Haight Online Pharmacy Consumer Protection Act of 2008; Correction (October 22, 2020)

Noramco Inc. (October 22, 2020)

Kinetochem LLC (October 22, 2020)

30-Day Notice: Drug Questionnaire (October 15, 2020)

Synthcon, LLC (October 14, 2020)

Euticals, Inc. (October 14, 2020)

Purisys, LLC (October 9, 2020)

Steven A. Holper, M.D.; Decision and Order (October 9, 2020)

Wayne Pharmacy; Decision and Order (October 8, 2020)

MMJ Biopharma Cultivation, Inc. (October 8, 2020)

Barbara D. Marino, M.D.; Decision and Order (October 7, 2020)

Jacqueline G. Curtis, M.D.; Decision and Order (October 7, 2020)

Stacey Lynne Schirmer, M.D.; Decision and Order (October 7, 2020)

Interim Final Rule: Placement of Remimazolam in Schedule IV (October 6, 2020)

Halo Pharmaceutical, Inc. (October 6, 2020)

S&B Pharma, LLC (October 6, 2020)

Eli Elsohly Laboratories (October 6, 2020)

Wildlife Laboratories, LLC (October 6, 2020)

Proposed Rule: Registering Emergency Medical Services Agencies Under the Protecting Patient Access to Emergency Medications Act of 2017 (October 5, 2020)

Final Order: Placement of Crotonyl Fentanyl in Schedule I (October 2, 2020)

---

September

Final Rule: Implementation of the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (September 30, 2020)

Proposed Rule: Default Provisions for Hearing Proceedings Relating to the Revocation, Suspension, or Denial of a DEA Registration (September 30, 2020)

Fisher Clinical Services, Inc. (September 24, 2020)

Caligor Coghlan Pharma Services (September 23, 2020)

Rhodes Technologies (September 18, 2020)

Cambrex High Point, Inc. (September 18, 2020)

Nalas Engineering Services, Inc. (September 18, 2020)

Bright Green Corporation (September 18, 2020)

Fisher Clinical Services, Inc. (September 18, 2020)

Organix Inc. (September 14, 2020)

Cambridge Isotype Lab (September 14, 2020)

Cerilliant Corporation (September 14, 2020)

Novitium Pharma LLC (September 14, 2020)

60-Day Notice: Drug Questionnaire (DEA-341) (September 9, 2020)

Nanosyn Inc. (September 9, 2020)

Cayman Chemical Company (September 8, 2020)

Cambridge Isotope Laboratories (September 8, 2020)

Aspen API, Inc. (September 8, 2020)

Proposed Adjustments to the Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2020 (September 1, 2020)

Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2021 (September 1, 2020)

---

August

Heavenly Care Pharmacy; Decision and Order (PDF) (August 28, 2020)

Proposed Rule: Placement of N-Ethylpentylone in Schedule I (August 27, 2020)

Temporary Rule: Extension of Temporary Placement of N-Ethylpentylone in Schedule I of the Controlled Substances Act (August 27, 2020)

Interim Final Rule: Implementation of the Agriculture Improvement Act of 2018 (August 21, 2020)

Final Rule: Placement of Cenobamate in Schedule V (August 20, 2020)

Temporary Order: Temporary Placement of Isotonitazene in Schedule I (August 20, 2020)

Morning Star Pharmacy & Medical Supply 1; Decision and Order (PDF) (August 19, 2020)

David Mwebe, M.D.; Decision and Order (August 19, 2020)

Cedarburg Pharmaceuticals (August 11, 2020)

Purisys, LLC (August 11, 2020)

National Center for Natural Products Research NIDA MPROJECT (August 11, 2020)

Mark D. Beale, M.D.; Decision and Order (August 11, 2020)

Cambrex High Point, Inc. (August 11, 2020)

Epic Pharma, LLC (August 11, 2020)

GE Healthcare (August 11, 2020)

Catalent CTS, LLC (August 11, 2020)

Tommy L. Louisville, M.D.; Decision and Order (August 10, 2020)

American Radiolabeled Chemicals, Inc (August 3, 2020)

Chattem Chemicals Inc (August 3, 2020)

Curium US LLC (August 3, 2020)